CASSAVA SCIENCES
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive.
CASSAVA SCIENCES
Social Links:
Industry:
Biopharma Biotechnology Life Science Medical Neuroscience Pharmaceutical
Founded:
1998-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.cassavasciences.com
Total Employee:
1+
Status:
Active
Contact:
(512) 501 - 2444
Total Funding:
206.9 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail ReCAPTCHA GoDaddy DNS ReCAPTCHA V2 Akamai Hosted Time Warner
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Cassava Sciences
National Institutes of Health
National Institutes of Health investment in Grant - Cassava Sciences
National Institutes of Health
National Institutes of Health investment in Grant - Cassava Sciences
Official Site Inspections
http://www.cassavasciences.com Semrush global rank: 1.51 M Semrush visits lastest month: 17.75 K
Unable to get host informations!!!
More informations about "Cassava Sciences" on Search Engine
Cassava Sciences Selects Clinical Research Organization for …
Selection of Premier Research as CRO Marks Significant Milestone Toward Initiation of Phase 3 Program of Simufilam in Alzheimer’s Disease. AUSTIN, Texas, June 21, 2021 …See details»
Cassava Sciences - Wikipedia
Cassava Sciences is an American pharmaceutical company based in Austin, Texas. The company was founded in 1998 by chief executive officer and president Remi Barbier as …See details»
Cassava Sciences Selects Clinical Research Organization for …
AUSTIN, Texas, June 21, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced the …See details»
Cassava Sciences Completes Enrollment for Pivotal Phase 3 …
Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. …See details»
Cassava Sciences Announces Completion of an Interim Safety …
AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced the …See details»
Cassava Sciences Announces Completion of an Interim Safety …
AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced the …See details»
Cassava Sciences Announces Significant Program Progress and …
February 8, 2021 · 9 min read. AUSTIN, Texas, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company …See details»
Cassava Sciences Announces Initiation of Cognition
AUSTIN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today …See details»
Cassava Sciences - Crunchbase Company Profile & Funding
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience. Austin, Texas, United States. 11-50. Post-IPO Equity. Public. …See details»
Cassava Sciences Selects Clinical Research Organization for
AUSTIN, Texas, June 21, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced the …See details»
Investor Relations | Cassava Sciences, Inc.
Investor Relations. Cassava Sciences, Inc. is a biopharmaceutical company that develops novel drugs. Presentations. Cassava Corporate Presentation – Second Quarter 2024. …See details»
Cassava Sciences Appoints Three New Members to its Board of …
AUSTIN, Texas, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today …See details»
Cassava Sciences Appoints Three New Members to its Board of …
Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. …See details»
Cassava Sciences - Funding, Financials, Valuation & Investors
Funding. Cassava Sciences has raised a total of. $256.9M. in funding over 5 rounds. Their latest funding was raised on Nov 18, 2022 from a Post-IPO Equity round. Cassava …See details»
Co-developer of Cassava’s potential Alzheimer’s drug ... - Science
Cassava Sciences, a biotech company whose work on the experimental Alzheimer’s drug simufilam has been heavily criticized and is the subject of ongoing federal probes, has …See details»
Cassava Sciences Annual Report 2023 - StockLight
Cassava Sciences Annual Report 2023 Form 10-K (NASDAQ:SAVA) Published: February 28th, 2023 PDF generated by stocklight.com . UNITED STATES ... incorporation or …See details»
CORPORATE GOVERNANCE | Cassava Sciences, Inc.
CORPORATE GOVERNANCE. The Board of Directors of Cassava Sciences, Inc. has developed and adopted a set of corporate governance principles to provide the …See details»
Cassava Sciences Announces Over $125 Million Raised from
Total net proceeds to Cassava Sciences from Warrants are estimated at over $123 million after deducting advisory fees and certain other expenses. The Company intends to use …See details»
Cassava Sciences - Contacts, Employees, Board Members, …
About. Cassava Sciences has 3 current employee profiles, including Chief Medical Officer Nadav Friedmann. Cassava Sciences has 4 board members and advisors, including …See details»
Cassava Sciences Announces Over $125 Million Raised from …
May. 8, 2024, 11:00 AM. AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”), a biotechnology company focused on …See details»